Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 1 40-1, 1996, Pages

  Suzuki, Hideyuki ^a   Noda, Yasuko ^a   Gao, Xiao Pei ^a   Séjourné, Florence ^a   Alkan Önyuksel, Hayat ^a   Paul, Sudhir ^a   Rubinstein, Israel ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

hamster; lipids; microcirculation; neuropeptides; resistance arterioles

Indexed keywords

LIPOSOME; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALPHA HELIX; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; CARDIOVASCULAR RESPONSE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG EFFECT; ENCAPSULATION; HAMSTER; HYPERTENSION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VASODILATATION;

EID: 33750813567     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.1.h282     Document Type: Article

References (30)

1. Brizzolara, A. L., and G. Burnstock. Endothelium-dependent and endothelium-independent vasodilatation of the hepatic artery of the rabbit. Br J. Pharmacol. 103: 1206-1212, 1991.
2. Duggan, K. A., D. M. Jones, R. E. Davis, and G. J. MacDonald. Effect of neutral endopeptidase on plasma and tissue concentrations of vaso-active intestinal peptide. Clin. Exp. Pharmacol. Physiol. 21: 307-309, 1994.
3. Frase, L. L., F. A. Gaffney, L. D. Lane, J. C. Buckey, S. I. Said, C. G. Blomqvist, and G. J. Krejs. Cardiovascular effects of vasoactive intestinal peptide in healthy subjects. Am. J. Cardiol. 60: 1356-1361, 1987.
4. Gao, X.-P., Y. Noda, I. Rubinstein, and S. Paul. Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure. Life Sci. 54: PL274-PL252, 1994.
5. G-monomethyl arginine in endothelium-denuded vessels. Br. J. Pharmacol. 102: 567-572, 1991.
6. Glubenkian, S., O. S. Opgaard, R. Ekman, N. C. Andrade, J. Wharton, J. M. Polak, J. Queiroz e Melo, and L. Edvinsson. Peptidergic innervation of human epicardial coronary arteries. Circ. Res. 73: 579-588, 1993.
7. Gregoriadis, G., and A. T. Florence. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. Drugs 45: 15-28, 1993.
8. Holzer, P., and P. H. Guth. Neuropeptide control of rat gastric mucosal blood flow. Increase by calcitonin gene-related peptide and vasoactive intestinal polypeptide, but not substance P and neurokinin A. Circ. Res. 68: 100-105, 1991.
9. Ignarro, L. J., R. E. Byrns, G. M. Buga, and K. S. Wood. Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. Am. J. Physiol. 253 (Heart Circ. Physiol. 22): H1074-H1082, 1987.
10. Itoh, H., K. P. Lederis, and O. P. Rorstad. Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide. Eur. J. Pharmacol. 181: 199-205, 1990.
11. Kaji, A., T. Maeda, and S. Watanabe. Parasympathetic innervation of cutaneous blood vessels examined by retrograde tracing in the rat lower lip. J. Auton. Nerv. Syst. 32: 153-158, 1991.
12. MacDonald, R. C., R. I. MacDonald, B. P. M. Menco, K. Takeshita, N. K. Subbararo, and L.-r. Hu. Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim. Biophys. Acta 1061: 297-303, 1991.
13. Mayhan, W. G., and W. L. Joyner. The effect of altering the external calcium concentration and a calcium channel blocker, verapamil, on microvascular leaky sites and dextran clearance in the hamster cheek pouch. Microvasc. Res. 28: 159-179, 1984.
14. Mayhan, W. G., and I. Rubinstein. Acetylcholine induces vasoconstriction in the microcirculation of cardiomyopathic hamsters: reversal by L-arginine. Biochem. Biophys. Res. Commun. 184: 1372-1377, 1992.
15. Miao, F. J.-P., and T. J.-F. Lee. VIP-ergic and cholinergic innervations in internal carotid arteries of the cat and rat. J. Cardiovasc. Pharmacol. 18: 369-378, 1991.
16. Musso, G. F., S. Patthi, T. C. Ryskamp, S. Provow, E. T. Kaiser, and G. Velicelebi. Development of helix-based vasoactive intestinal peptide analogues: identification of residues required for receptor interaction. Biochemistry 27: 8174-8181, 1988.
17. Noda, Y., J. Rodriguez-Sierra, J. Liu, D. Landers, A. Mori, and S. Paul. Partitioning of vasoactive intestinal polypeptide into lipid bilayers. Biochim. Biophys. Acta 1191: 324-330, 1994.
18. Paaza, J. A., P. R. Casino, C. M. Kilocoyne, and A. A. Quyyumi. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J. Am. Coll. Cardiol. 23: 1610-1616, 1994.
19. Paul, S., D. J. Volle, C. M. Beach, D. R. Johnson, M. J. Powell, and R. J. Massey. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science Wash. DC 244: 1158-1162, 1989.
20. Raud, J. Intravital microscopic studies on acute mast cell-dependent inflammation. Acta Physiol. Scand. Suppl. 578: 1-58, 1989.
21. Robinson, R. M., E. W. Blakeney, Jr., and W. L. Mattice. Lipid-induced conformational changes in glucagon, secretin, and vasoactive intestinal peptide. Biopolymers 21: 1217-1228, 1982.
22. Rorstad, O. P., I. Wanke, D. H. Coy, A. Fournier, and M. Huang. Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide. Mol. Pharmacol. 37: 971-977, 1990.
23. Rubinstein, I., M. Houmsse, R. G. Davis, and J. K. Vishwanatha. Tissue angiotensin I-converting enzyme activity in spontaneously hypertensive hamsters. Biochem. Biophys. Res. Commun. 183: 1117-1123, 1992.
24. Rubinstein, I., and W. G. Mayhan. L-Arginine dilates cheek pouch arterioles in hamsters with hereditary cardiomyopathy but not in controls J. Lab. Clin. Med. 125: 313-318, 1995.
25. Rubinstein, I., T. Yong, S. I. Rennard, and W. G. Mayhan. Cigarette smoke extract attenuates endothelium-dependent arteriolar dilatation in vivo. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1913-H1918, 1991.
26. Soloviev, A. I., A. V. Stefanov, O. V. Bazilyuk, and V. F. Sagach. Phospholipid vesicles (liposomes) restore endothelium-dependent cholinergic relaxation in thoracic aorta from spontaneously hypertensive rats. J. Hypertens. 11: 623-627, 1993.
27. 1 receptors expressed by stable transfectants couple to two distinct signaling pathways. Biochem. Biophys. Res. Commun. 203: 141-148, 1994.
28. Stallwood, D., C. H. Brugger, B. A. Baggenstoss, P. M. Stemmer, H. Shiraga, D. F. Landers, and S. Paul. Identity of a membrane-bound vasoactive intestinal peptide-binding protein with calmodulin. J. Biol. Chem. 267: 19617-19621, 1992.
29. Suzuki, H., Y. Noda, S. Paul, S. X.-p. Gao, and I. Rubinstein. Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo. Life Sci. 57: 1451-1457, 1995.
30. Woie, L., K. Dickstein, and B. Kaada. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes. Gen. Pharmacol. 18: 577-587, 1987.